Ligand validation:3CAV

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3CAV_EDO_A_332	60%	34%	0.12	0.906	2.29	0.37	1	-	0	0	100%	1
3CAV_EDO_B_330	55%	33%	0.127	0.894	2.34	0.39	1	-	0	0	100%	1
3CAV_EDO_A_330	54%	30%	0.177	0.944	2.42	0.41	1	-	2	0	100%	1
3CAV_EDO_A_331	45%	33%	0.161	0.894	2.33	0.36	1	-	1	0	100%	1
3CAV_EDO_B_331	26%	33%	0.267	0.911	2.33	0.38	1	-	0	0	100%	1
3CAS_EDO_A_330	48%	35%	0.14	0.884	2.29	0.34	1	-	1	0	100%	1
3CAQ_EDO_A_329	43%	35%	0.102	0.824	2.29	0.31	1	-	1	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4ITB_EDO_A_503	100%	88%	0.028	0.99	0.38	0.29	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.